Atopic Dermatitis Clinical Trials

A randomised, double-blind, placebo-controlled, phase 3 trial to evaluate the efficacy and safety of an injectable medication, tralokinumab, in combination with topical corticosteroids in subjects with moderate-to-severe atopic dermatitis who are candidates for systemic therapy.

Now enrolling ages 18 and older for moderate to severe atopic dermatitis.

This is a double-blind, randomized, placebo-controlled study to assess the efficacy, safety, and tolerability of serlopitant for the treatment of pruritus (itching) in adults with prurigo nodularis (abbreviated as PN, a skin condition with multiple very itchy, solid skin bumps that develop due to scratching).  All enrolled subjects will receive ...

This study will be evaluating the efficacy, tolerability and safety of lebrikizumab compared to placebo in subjects with moderate to severe atopic dermatitis. This is a phase 2b, randomized, placebo-controlled, double-blind study in which subjects will be randomized to receive either lebrikizumab 125mg every 4 weeks, 250mg every 2 weeks, ...

This registry aims to characterize the patients who receive DUPIXENT for atopic dermatitis (AD) in a real world setting, with respect to their medical history, socio-demographic and disease characteristics, and prior and concomitant treatments of AD.

Participants with atopic dermatitis and eczema conditions will be given a lotion to use over the course of 4 weeks. They will be asked to return to the clinic at weeks 2 and 4 where assessments will be done to see how effective the lotion is.

The OXFORAD™ Study for Atopic Dermatitis is examining an investigational drug to see how safe and effective it is when given to people like you who have eczema.

A research study is evaluating an investigational medication for moderate to severe atopic dermatitis, also known as eczema.

A Randomized, Double-Blind, Placebo-Controlled, Phase 2B Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of ASN002 in Subjects With Moderate to Severe Atopic Dermatitis

A clinical trial designed to evaluate the safety and effectiveness of a new investigational medication under development for adult patients with moderate to-severe atopic dermatitis is currently being conducted. All subjects will receive injections of trial medication every other week for up to 32 weeks. For all trial participants, the ...